VIO Chemicals awarded with European Commission’s Seal of Excellence

23 May 2019

The European Commission has recently awarded VIO Chemicals with the Seal of Excellence, a high-quality label for first-class innovation ideas worthy of investment.

With this award the European Commission recognizes VIO Chemicals as a highly innovative enterprise with clear potential to compete internationally in high-growth markets.

VIO Chemicals awarded with European Commission’s Seal of Excellence

“For us at VIO Chemicals, it is an honour to have our efforts recognized. The recognition is more fulfilling as it comes by an international panel of independent experts in a highly competitive evaluation process in terms of excellence, impact, quality and efficiency of implementation”, commented VIO Chemicals CEO and founder, Dimitris Kalias.

“We are very proud that our project scored highly against nearly 3,000 applicants and this award reinforces our commitment to integrating innovation as a value and approach in all of our work”.

The Seal of Excellence is the Certificate of high quality awarded to projects submitted to Horizon 2020 Programme, which have passed all the stringent selection and award criteria but could not get funded due to Horizon 2020 budget limits. The “Seal” identifies the business value of the VIO Chemicals proposal and merits funding from alternative sources, public, private, national, regional European or international.

Read More

Related news

HALIX starts operational production with new cGMP facility in Q4-2019

HALIX starts operational production with new cGMP facility in Q4-2019

15 Aug 2019

The five-level production facility contains a state-of-the-art manufacturing line for viral vaccines and viral vectors and a separate protein manufacturing area with a capacity up to 1,000-L single-use bioreactors.

Read more 
Delivering complete aseptic vial handling solutions

Delivering complete aseptic vial handling solutions

14 Aug 2019

Bringing freeze drying and vial washing/sterilizing technologies together with advanced and comprehensive vial and syringe filling capabilities.

Read more 
Hikma expands nasal spray capabilities

Hikma expands nasal spray capabilities

12 Aug 2019

Company acquires unit-dose nasal and sublingual spray manufacturing equipment, as well as two pipeline products.

Read more 
How real-world data can revolutionise drug development

How real-world data can revolutionise drug development

9 Aug 2019

Utilising the current data environment and its data pools for the benefit of advancing research.

Read more 
Sartorius launches new services for mammalian cell bank manufacturing

Sartorius launches new services for mammalian cell bank manufacturing

8 Aug 2019

Integrated package of new and established services saves time and minimizes risks.

Read more 
Using mobile phones to fight Alzheimer’s disease

Using mobile phones to fight Alzheimer’s disease

8 Aug 2019

Researchers study how radiofrequency electromagnetic fields could be used in Alzheimer’s disease therapy.

Read more 
Cambrex to be acquired by the Permira funds

Cambrex to be acquired by the Permira funds

7 Aug 2019

The CDMO's shareholders will receive $60.00 per share in cash.

Read more 
Automation-compatible prepared culture media plate technology

Automation-compatible prepared culture media plate technology

6 Aug 2019

Thermo Fisher Scientific's SmartPlate format brings together Oxoid and Remel prepared culture media with a durable, universal plate design, helping customers to deliver accurate results across both automated and manual methods.

Read more 
Colorcon to incorporate TruTag's edible 'optical barcodes' in tablet film coatings

Colorcon to incorporate TruTag's edible 'optical barcodes' in tablet film coatings

6 Aug 2019

The benefits of this innovation include the ability to instantly and unequivocally authenticate products when suspect events.

Read more 
Growing domestic manufacturing creates new opportunities for international pharma in the Middle East

Growing domestic manufacturing creates new opportunities for international pharma in the Middle East

5 Aug 2019

Opportunities abound at CPhI MEA and experts anticipate regional generic companies acting as CMOs for international companies looking to enter the region.

Read more